These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 8008057)

  • 1. Tumour diagnosis.
    Hall PA; Dowell SP; Lane DP
    Nature; 1994 Jun; 369(6483):701. PubMed ID: 8008057
    [No Abstract]   [Full Text] [Related]  

  • 2. p53: it has it all, but will it make it to the clinic as a marker in bladder cancer?
    Real FX
    J Clin Oncol; 2007 Dec; 25(34):5341-4. PubMed ID: 18048811
    [No Abstract]   [Full Text] [Related]  

  • 3. P53 expression in small cell carcinoma of the urinary bladder: biological and prognostic implications.
    Wang X; Jones TD; Maclennan GT; Yang XJ; Lopez-Beltran A; Eble JN; Koch MO; Lin H; Baldridge LA; Tretiakova M; Cheng L
    Anticancer Res; 2005; 25(3B):2001-4. PubMed ID: 16158936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
    Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of p53 nuclear overexpression and MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder.
    Popov Z; Hoznek A; Colombel M; Bastuji-Garin S; Lefrere-Belda MA; Bellot J; Abboh CC; Mazerolles C; Chopin DK
    Cancer; 1997 Oct; 80(8):1472-81. PubMed ID: 9338472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered p53 and pRb expression is predictive of response to BCG treatment in T1G3 bladder cancer.
    Cormio L; Tolve I; Annese P; Saracino A; Zamparese R; Sanguedolce F; Bufo P; Battaglia M; Selvaggi FP; Carrieri G
    Anticancer Res; 2009 Oct; 29(10):4201-4. PubMed ID: 19846973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four tumour markers for urinary bladder cancer--tissue polypeptide antigen (TPA), HER-2/neu (ERB B2), urokinase-type plasminogen activator receptor (uPAR) and TP53 mutation.
    Ecke TH; Schlechte HH; Schulze G; Lenk SV; Loening SA
    Anticancer Res; 2005; 25(1B):635-41. PubMed ID: 15816639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy.
    Zlotta AR; Noel JC; Fayt I; Drowart A; Van Vooren JP; Huygen K; Simon J; Schulman CC
    J Urol; 1999 Mar; 161(3):792-8. PubMed ID: 10022686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 gene and protein status: the role of p53 alterations in predicting outcome in patients with bladder cancer.
    George B; Datar RH; Wu L; Cai J; Patten N; Beil SJ; Groshen S; Stein J; Skinner D; Jones PA; Cote RJ
    J Clin Oncol; 2007 Dec; 25(34):5352-8. PubMed ID: 18048815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The p53 positivity in non-tumor mucosa in patients with superficial urinary bladder cancer].
    Soukup V; Babjuk M; Dusková J; Pesl M; Szakácsova M; Zámefnik L; Dvorácek J
    Cas Lek Cesk; 2007; 146(1):63-7. PubMed ID: 17310587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between expression of the KAI1 metastasis suppressor and other markers of advanced bladder cancer.
    Ow K; Delprado W; Fisher R; Barrett J; Yu Y; Jackson P; Russell PJ
    J Pathol; 2000 May; 191(1):39-47. PubMed ID: 10767717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 and RB: simple interesting correlates or tumor markers of critical predictive nature?
    Cordon-Cardo C
    J Clin Oncol; 2004 Mar; 22(6):975-7. PubMed ID: 14981108
    [No Abstract]   [Full Text] [Related]  

  • 13. Reproducibility of p53 immunohistochemistry in bladder tumors. National Cancer Institute, Bladder Tumor Marker Network.
    McShane LM; Aamodt R; Cordon-Cardo C; Cote R; Faraggi D; Fradet Y; Grossman HB; Peng A; Taube SE; Waldman FM
    Clin Cancer Res; 2000 May; 6(5):1854-64. PubMed ID: 10815908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein expression and gene copy number analysis of topoisomerase 2alpha, HER2 and P53 in minimally invasive urothelial carcinoma of the urinary bladder--a multitissue array study with prognostic implications.
    Krüger S; Lange I; Kausch I; Feller AC
    Anticancer Res; 2005; 25(1A):263-71. PubMed ID: 15816547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 expression compared with other prognostic factors in OMS grade-I stage-Ta transitional cell carcinoma of the bladder.
    Casetta G; Gontero P; Russo R; Pacchioni D; Tizzani A
    Eur Urol; 1997; 32(2):229-36. PubMed ID: 9286659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological markers of prognosis in transitional cell carcinoma of the bladder: current concepts.
    Aprikian AG; Sarkis AS; Reuter VE; Cordon-Cardo C; Sheinfeld J
    Semin Urol; 1993 Aug; 11(3):137-44. PubMed ID: 8210835
    [No Abstract]   [Full Text] [Related]  

  • 17. Calcitonin-producing well-differentiated neuroendocrine carcinoma (carcinoid tumor) of the urinary bladder: case report.
    Mascolo M; Altieri V; Mignogna C; Napodano G; De Rosa G; Insabato L
    BMC Cancer; 2005 Jul; 5():88. PubMed ID: 16048646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal analysis of human recurrent superficial bladder cancer by immunohistochemistry of P53 and retinoblastoma proteins.
    Chern HD; Becich MJ; Persad RA; Romkes M; Smith P; Collins C; Li YH; Branch RA
    J Urol; 1996 Nov; 156(5):1846-9. PubMed ID: 8863629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective evaluation of p53 as a prognostic marker in T1 transitional cell carcinoma of the bladder.
    Dalbagni G; Parekh DJ; Ben-Porat L; Potenzoni M; Herr HW; Reuter VE
    BJU Int; 2007 Feb; 99(2):281-5. PubMed ID: 17155984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of cell cycle biomarkers in nonmuscle invasive bladder transitional cell carcinoma.
    Shariat SF; Ashfaq R; Sagalowsky AI; Lotan Y
    J Urol; 2007 Feb; 177(2):481-7; discussion 487. PubMed ID: 17222615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.